Physicians
Overview
Cellvizio system
Education
Reimbursement
GastroEnterology
Barrett’s Esophagus
Pancreatic Cysts
Gastric Disease
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Bilio-Pancreatic Strictures
Colorectal Lesions
Pulmonology
Lung Nodules
Covid-19
Urology
Investors
About us
Our story
Team
Board of Directors
Leadership
Join Us
Commercial Network
News & events
US
INT
FR
US
INT
FR
Contact
Search
Search
All
EVENTS
NEWS
OPINION
PUBLICATIONS
All
January
February
March
April
May
June
July
August
September
October
November
December
Date added (latest)
Date added (oldest)
News & Events
NEWS - Cellvizio
May 18, 2022
On Target Laboratories and Mauna Kea Technologies Demonstrate Intraprocedural Targeted Detection of Lung Cancer with a Molecular Imaging Agent
Discover
NEWS - Cellvizio
Apr 21, 2022
Mauna Kea Technologies publishes Q1 2022 sales and its 2021 financial results
Discover
NEWS - Cellvizio
Apr 12, 2022
Mauna Kea Technologies Announces First of Its Kind U.S. FDA 510(k) Clearance for Use of Cellvizio in a New Category of Molecular Imaging-guided Endoscopic, Laparoscopic, Needle-Based Procedures
Discover
EVENTS - Cellvizio
Mar 17, 2022
Mauna Kea Technologies to Present at 32nd Annual Oppenheimer Healthcare Conference on March 17, 2022
Discover
NEWS - Cellvizio
Mar 8, 2022
On Target Laboratories and Mauna Kea Technologies Announce a Novel Clinical Research and Product Development Collaboration
Discover
NEWS - Cellvizio
Feb 22, 2022
Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial
Discover
See more
